Patents by Inventor Simon T. Russell

Simon T. Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinoline derivatives and use thereof as angiotensin II antagonists
    Patent number: 5444071
    Abstract: The invention concerns pharmaceutically useful novel compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Ra, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.
    Type: Grant
    Filed: May 4, 1993
    Date of Patent: August 22, 1995
    Assignee: Imperial Chemical Industries PLC
    Inventors: David A. Roberts, Simon T. Russell, Robert J. Pearce
  • Benz[4,5]imidazole-containing angiotensin antagonists
    Patent number: 5171748
    Abstract: The invention concerns novel heterocyclic compounds of the formula I as defined herein and their physiologically acceptable salts, together with pharmaceutical compositions containing them. The heterocyclic compounds antagonize the actions of angiotensin II and are of value in treating diseases or medical conditions such as hypertension and congestive heart failure in warm-blooded animals. The invention further includes processes for the manufacture of the novel compounds and their use in medical treatment.
    Type: Grant
    Filed: May 22, 1990
    Date of Patent: December 15, 1992
    Assignee: Imperial Chemical Industries plc
    Inventors: David A. Roberts, Simon T. Russell